Prostate-specific Antigen (PSA) Testing Is Prevalent and Increasing in Stockholm County, Sweden, Despite No Recommendations for PSA Screening: Results from a Population-based Study, 2003

Prostate-specific Antigen (PSA) Testing Is Prevalent and Increasing in Stockholm County, Sweden, Despite No Recommendations for PSA Screening: Results from a Population-based Study, 2003–2011

Published:2013-03 Issue:3 Volume:63 Page:419-425
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Nordström Tobias,Aly Markus,Clements Mark S.,Weibull Caroline E.,Adolfsson Jan,Grönberg Henrik

Publisher

Elsevier BV

Subject

Urology

Reference27 articles.

1. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate;Stamey;N Engl J Med,1987

2. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer;Oesterling;JAMA,1993

3. Age-specific reference ranges for serum prostate-specific antigen;Anderson;Urology,1995

4. Predictive properties of serum-prostate-specific antigen testing in a community-based setting;Jacobsen;Arch Intern Med,1996

5. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lower;Thompson;JAMA,2005

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiparametric magnetic resonance imaging and magnetic resonance imaging fusion-guided biopsy for the diagnosis of prostate cancer: current status;Digital Diagnostics;2024-09-11

2. Spatio-temporal variation in prostate cancer testing in Stockholm: A population-based study;PLOS ONE;2024-08-15

3. Prostate cancer incidence and mortality in men exposed to α1-adrenergic receptor antagonists;JNCI: Journal of the National Cancer Institute;2024-05-08

4. Effectiveness and Cost-effectiveness of Artificial Intelligence–assisted Pathology for Prostate Cancer Diagnosis in Sweden: A Microsimulation Study;European Urology Oncology;2024-05

5. Prediagnostic Prostate-specific Antigen Testing and Clinical Characteristics in Men with Lethal Prostate Cancer;European Urology Open Science;2024-04